Search
Abbott Laboratories
ABTAdd to Watchlist
88.410USD
-0.120-0.14%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
153.99BMarket Cap
24.53P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Abbott Laboratories is 8.00, ranking 66 out of 203 in the Healthcare Equipment & Supplies industry. The average price target is 145.00, with a high of 162.00 and a low of 122.34.
Analyst Rating
Based on
30
analysts
Buy
Current Rating
117.682
Target Price
+32.97%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
117
Total
6
Median
9
Average
Company name
Ratings
Analysts
Abbott Laboratories
ABT
30
Medtronic PLC
MDT
33
Dexcom Inc
DXCM
32
Stryker Corp
SYK
32
Zimmer Biomet Holdings Inc
ZBH
31
Medline Ord Shs Class A
MDLN
29
1
2
3
...
24
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Abbott Laboratories's expected revenue for the next quarter?
Abbott Laboratories's expected revenue is 12.53B.
What is Abbott Laboratories's price target?
Analysts forecast that Abbott Laboratories's price target is USD 145.00, with the highest forecast at USD 162.00 and the lowest forecast at USD 122.34.
How have Abbott LaboratoriesABT's recent earnings per share performed?
The market expectation was USD 0.62, while Abbott LaboratoriesABT's earnings per share (EPS) for the previous quarter was USD 1.02. EPS for the next quarter is expected at USD 1.28.
What is the analyst rating for Abbott Laboratories?
Based on the ratings of Abbott Laboratories's stock from 30 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
